- Tytuł:
- Effect of Empagliflozin with or without the Addition of Evolocumab on HDL Subspecies in Individuals with Type 2 Diabetes Mellitus: A Post Hoc Analysis of the EXCEED-BHS3 Trial.
- Autorzy:
- Corporate Authors:
- EXCEED-BHS3 Group
- Źródło:
-
International journal of molecular sciences [Int
J Mol Sci] 2024 Apr 08; Vol. 25 (7). Date of Electronic Publication: 2024 Apr 08. - Typ publikacji:
- Journal Article
- MeSH Terms:
-
Diabetes Mellitus, Type 2*/drug therapy
Benzhydryl Compounds*
Glucosides*
Humans ; Antibodies, Monoclonal, Humanized/therapeutic use ; Cholesterol, HDL
Czasopismo naukowe